MarcyMarc的个人主页 - 老虎社区

MarcyMarc

MarcyMarc

暂无个人介绍

IP属地：未知

4关注

1粉丝

0主题

0勋章

2021-08-26

Nice

抱歉，原内容已删除

2021-06-30

Yep

This Hot Reddit Stock Just Gave Investors an Ominous Warning

2021-06-29

Buy $$

2021-06-29

Haha

抱歉，原内容已删除

2021-06-29

O

2 Robinhood Stocks That Could Crush Dogecoin

2021-06-17

O

抱歉，原内容已删除

2021-06-01

You’re a dreamer mate if you think apple is gonna drop below $90. What a joker

Apple Stock To Sink 30%? Inside The Mind Of A Bear

2021-03-10

$Exxon Mobil(XOM)$🚀

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3574486316260209","uuid":"3574486316260209","gmtCreate":1611936904393,"gmtModify":1615358724479,"name":"MarcyMarc","pinyin":"marcymarc","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/676954ae064ead813cc75835e6ca0924","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":4,"tweetSize":8,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.06.15","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.98%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":810119322,"gmtCreate":1629951371266,"gmtModify":1633681217102,"author":{"id":"3574486316260209","authorId":"3574486316260209","name":"MarcyMarc","avatar":"https://static.tigerbbs.com/676954ae064ead813cc75835e6ca0924","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574486316260209","idStr":"3574486316260209"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/810119322","repostId":"2162525350","repostType":4,"isVote":1,"tweetType":1,"viewCount":129,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":153236495,"gmtCreate":1625026535017,"gmtModify":1633945678020,"author":{"id":"3574486316260209","authorId":"3574486316260209","name":"MarcyMarc","avatar":"https://static.tigerbbs.com/676954ae064ead813cc75835e6ca0924","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574486316260209","idStr":"3574486316260209"},"themes":[],"htmlText":"Yep","listText":"Yep","text":"Yep","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/153236495","repostId":"2147585034","repostType":4,"repost":{"id":"2147585034","kind":"highlight","pubTimestamp":1625024760,"share":"https://ttm.financial/m/news/2147585034?lang=&edition=full","pubTime":"2021-06-30 11:46","market":"us","language":"en","title":"This Hot Reddit Stock Just Gave Investors an Ominous Warning","url":"https://stock-news.laohu8.com/highlight/detail?id=2147585034","media":"Motley Fool","summary":"It's a warning that investors should take seriously.","content":"<p>This year was shaping up to be a miserable <a href=\"https://laohu8.com/S/AONE\">one</a> for&nbsp;<b>Clover Health</b> (NASDAQ:CLOV). Note the use of the past tense in that statement, though. Thanks in large part to Reddit users piling on, Clover's shares have soared in recent weeks.</p>\n<p>Don't think that the waters are safe to jump aboard the bandwagon for Clover Health yet, however.&nbsp;Here's why this hot Reddit stock just gave investors an ominous warning.</p>\n<h2>Brutal honesty</h2>\n<p>All publicly traded companies want investors to buy their shares. Buying tends to beget more buying, which pushes the stock price up. It's rare that any company warns investors not to buy its stock. But that's exactly what Clover Health did recently.</p>\n<p>Companies that plan to issue additional shares file a prospectus with the U.S. Securities and Exchange Commission (SEC). This prospectus gives potential investors a lot of information about the business and lays out the key reasons why they might want to buy the new shares.</p>\n<p>Clover Health filed such a prospectus earlier this year, outlining its intent to issue additional Class B shares. These shares don't have the same level of voting rights as its Class A shares. Last week, the company submitted an amendment to the SEC for this prospectus. And that amendment contained a brutally honest message for potential investors.</p>\n<p>The company acknowledged that its recent gains could be due to a short squeeze. Because of the potential for an additional short squeeze and its aftermath, Clover Health gave an unusually stark warning to investors: \"Under the circumstances, we caution you against investing in our Class B common stock, unless you are prepared to incur the risk of losing all or a substantial portion of your investment.\" It also noted, \"Investors that purchase shares of our Class A common stock during a short squeeze may lose a significant portion of their investment.\"</p>\n<h2>No fear?</h2>\n<p>Clover Health explained clearly what could happen with both its Class A and Class B shares. The company stated that if another short squeeze happens, once short-sellers cover their positions or if investors otherwise think the short squeeze has run its course, its stock price could fall quickly.</p>\n<p>You might think that such an ominous warning would scare off many investors. Nope. Instead, it produced an opposite effect. Last week, shares of Clover Health soared by a double-digit percentage immediately after the company's amended prospectus with the serious warning was submitted to the SEC.</p>\n<p>This reaction might seem counterintuitive. After all, Clover Health informed investors in no uncertain terms about the risks they face with buying the stock. So why did the shares of the company surge instead of sink? I think there are different reasons for different investors.</p>\n<p>Some truly believe in Clover Health and are willing to hold onto the stock regardless of what happens over the short term. Others are fully aware that the gains generated by a short squeeze could evaporate quickly but think they'll be able to sell in time to still make a big profit. Unfortunately, there could also be some who are new to investing and didn't pay attention to or didn't understand Clover Health's cautionary message.</p>\n<h2>Business vs. stock</h2>\n<p>It's always wise to think of buying a stock as buying a part of a business. That's exactly what you're doing when you buy shares of Clover Health or any other company. When the underlying business is strong and has great prospects, you don't have to be concerned about short-term volatility with the share price.</p>\n<p>However, there are times when share prices get way out of alignment with the prospects of the underlying business. Short squeezes can often make this happen. In these cases, it's especially important to be careful in buying a stock. Sure, you're still buying a part of a business -- but you can pay a lot more than the business is actually worth.</p>\n<p>In my view, there are several reasons to like Clover Health's underlying business. The company has an intriguing technology that physicians use. It's expanding into the original Medicare market, a move that could boost sales tremendously. Clover Health has a visionary management team.</p>\n<p>But buying a stock that's a short squeeze candidate is risky if you aren't ready, willing, and able to sell shares immediately once the short squeeze ends. When a company issues a warning like Clover Health just did, the smart thing to do is to listen and take that warning seriously.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This Hot Reddit Stock Just Gave Investors an Ominous Warning</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Hot Reddit Stock Just Gave Investors an Ominous Warning\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-30 11:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/29/this-hot-reddit-stock-just-gave-investors-an-omino/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>This year was shaping up to be a miserable one for Clover Health (NASDAQ:CLOV). Note the use of the past tense in that statement, though. Thanks in large part to Reddit users piling on, Clover's ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/29/this-hot-reddit-stock-just-gave-investors-an-omino/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CLOV":"Clover Health Corp"},"source_url":"https://www.fool.com/investing/2021/06/29/this-hot-reddit-stock-just-gave-investors-an-omino/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2147585034","content_text":"This year was shaping up to be a miserable one for Clover Health (NASDAQ:CLOV). Note the use of the past tense in that statement, though. Thanks in large part to Reddit users piling on, Clover's shares have soared in recent weeks.\nDon't think that the waters are safe to jump aboard the bandwagon for Clover Health yet, however. Here's why this hot Reddit stock just gave investors an ominous warning.\nBrutal honesty\nAll publicly traded companies want investors to buy their shares. Buying tends to beget more buying, which pushes the stock price up. It's rare that any company warns investors not to buy its stock. But that's exactly what Clover Health did recently.\nCompanies that plan to issue additional shares file a prospectus with the U.S. Securities and Exchange Commission (SEC). This prospectus gives potential investors a lot of information about the business and lays out the key reasons why they might want to buy the new shares.\nClover Health filed such a prospectus earlier this year, outlining its intent to issue additional Class B shares. These shares don't have the same level of voting rights as its Class A shares. Last week, the company submitted an amendment to the SEC for this prospectus. And that amendment contained a brutally honest message for potential investors.\nThe company acknowledged that its recent gains could be due to a short squeeze. Because of the potential for an additional short squeeze and its aftermath, Clover Health gave an unusually stark warning to investors: \"Under the circumstances, we caution you against investing in our Class B common stock, unless you are prepared to incur the risk of losing all or a substantial portion of your investment.\" It also noted, \"Investors that purchase shares of our Class A common stock during a short squeeze may lose a significant portion of their investment.\"\nNo fear?\nClover Health explained clearly what could happen with both its Class A and Class B shares. The company stated that if another short squeeze happens, once short-sellers cover their positions or if investors otherwise think the short squeeze has run its course, its stock price could fall quickly.\nYou might think that such an ominous warning would scare off many investors. Nope. Instead, it produced an opposite effect. Last week, shares of Clover Health soared by a double-digit percentage immediately after the company's amended prospectus with the serious warning was submitted to the SEC.\nThis reaction might seem counterintuitive. After all, Clover Health informed investors in no uncertain terms about the risks they face with buying the stock. So why did the shares of the company surge instead of sink? I think there are different reasons for different investors.\nSome truly believe in Clover Health and are willing to hold onto the stock regardless of what happens over the short term. Others are fully aware that the gains generated by a short squeeze could evaporate quickly but think they'll be able to sell in time to still make a big profit. Unfortunately, there could also be some who are new to investing and didn't pay attention to or didn't understand Clover Health's cautionary message.\nBusiness vs. stock\nIt's always wise to think of buying a stock as buying a part of a business. That's exactly what you're doing when you buy shares of Clover Health or any other company. When the underlying business is strong and has great prospects, you don't have to be concerned about short-term volatility with the share price.\nHowever, there are times when share prices get way out of alignment with the prospects of the underlying business. Short squeezes can often make this happen. In these cases, it's especially important to be careful in buying a stock. Sure, you're still buying a part of a business -- but you can pay a lot more than the business is actually worth.\nIn my view, there are several reasons to like Clover Health's underlying business. The company has an intriguing technology that physicians use. It's expanding into the original Medicare market, a move that could boost sales tremendously. Clover Health has a visionary management team.\nBut buying a stock that's a short squeeze candidate is risky if you aren't ready, willing, and able to sell shares immediately once the short squeeze ends. When a company issues a warning like Clover Health just did, the smart thing to do is to listen and take that warning seriously.","news_type":1,"symbols_score_info":{"CLOV":0.9,"JE":0.9}},"isVote":1,"tweetType":1,"viewCount":97,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159614987,"gmtCreate":1624962079249,"gmtModify":1633946494973,"author":{"id":"3574486316260209","authorId":"3574486316260209","name":"MarcyMarc","avatar":"https://static.tigerbbs.com/676954ae064ead813cc75835e6ca0924","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574486316260209","idStr":"3574486316260209"},"themes":[],"htmlText":"Buy $$","listText":"Buy $$","text":"Buy $$","images":[{"img":"https://static.tigerbbs.com/23fe58a34f77ede65dad592912c6be86","width":"1125","height":"3005"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/159614987","isVote":1,"tweetType":1,"viewCount":86,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":159611198,"gmtCreate":1624961624914,"gmtModify":1633946497783,"author":{"id":"3574486316260209","authorId":"3574486316260209","name":"MarcyMarc","avatar":"https://static.tigerbbs.com/676954ae064ead813cc75835e6ca0924","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574486316260209","idStr":"3574486316260209"},"themes":[],"htmlText":"Haha&nbsp;","listText":"Haha&nbsp;","text":"Haha","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/159611198","repostId":"1176831724","repostType":4,"isVote":1,"tweetType":1,"viewCount":86,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159613338,"gmtCreate":1624961552524,"gmtModify":1633946498723,"author":{"id":"3574486316260209","authorId":"3574486316260209","name":"MarcyMarc","avatar":"https://static.tigerbbs.com/676954ae064ead813cc75835e6ca0924","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574486316260209","idStr":"3574486316260209"},"themes":[],"htmlText":"O","listText":"O","text":"O","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/159613338","repostId":"2146388793","repostType":4,"repost":{"id":"2146388793","kind":"highlight","pubTimestamp":1624959775,"share":"https://ttm.financial/m/news/2146388793?lang=&edition=full","pubTime":"2021-06-29 17:42","market":"us","language":"en","title":"2 Robinhood Stocks That Could Crush Dogecoin","url":"https://stock-news.laohu8.com/highlight/detail?id=2146388793","media":"Motley Fool","summary":"They're already big winners but could have much more room to run.","content":"<p><b>Dogecoin</b> (CRYPTO:DOGE) fans would be quick to point out that the cryptocurrency has skyrocketed more than 4,500% year to date. What started out as a joke has enabled some to laugh all the way to the bank.</p>\n<p>On the other hand, skeptics about Dogecoin would be just as quick to note that it has given up more than 60% of its earlier gains. Anyone who jumped on the Dogecoin late is probably sitting on some hefty losses.</p>\n<p>Regardless of what your take is on Dogecoin, what really matters is where you should put your money now. One place to get some investment ideas is Robinhood's 100 most popular stocks list. Here are two popular Robinhood stocks that could crush Dogecoin going forward.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/21859b0af15cb96a0c3a3aa3d6358251\" tg-width=\"700\" tg-height=\"420\" referrerpolicy=\"no-referrer\"><span>Image source: Getty Images.</span></p>\n<h2>NVIDIA</h2>\n<p>While Dogecoin has nosedived in recent months, <b>NVIDIA</b> (NASDAQ:NVDA) stock has taken off. One reason why is NVIDIA's upcoming four-for-<a href=\"https://laohu8.com/S/AONE\">one</a> stock split. While stock splits don't impact a company's valuation directly, they can attract greater numbers of small investors.</p>\n<p>However, there are plenty of even better reasons to like NVIDIA that have nothing to do with its stock split. The most obvious one is the company's gaming business.</p>\n<p>Gaming remains NVIDIA's biggest moneymaker, generating $2.8 billion of the company's total revenue of nearly $5.7 billion in the first quarter of 2021. And business is booming. NVIDIA's gaming revenue more than doubled year over year.</p>\n<p>It isn't just that gaming is increasing in popularity (although that is the case). NVIDIA benefits from regular hardware upgrade cycles. New games require even more processing power, which drives demand for the more powerful graphics processing units (GPUs).</p>\n<p>I especially like that NVIDIA is leveraging its gaming expertise to target new markets. For example, the company recently unveiled Omniverse Enterprise, a platform where design teams can build 3D virtual simulations and collaborate in real-time. In effect, NVIDIA is turning work into play (or vice versa, depending on how you look at it).</p>\n<p>NVIDIA CFO Colette Kress said in the company's Q1 conference call, \"As the world becomes more digital, virtual and collaborative, we see a significant revenue opportunity for Omniverse.\" I think that Kress's optimism is well-founded.</p>\n<p>Don't overlook NVIDIA's potential in the data center market, though. The company posted data center revenue of more than $2 billion in Q1, up 79% year over year. NVIDIA should enjoy sustained growth as more applications include artificial intelligence (AI).</p>\n<p>Assuming NVIDIA's pending acquisition of Arm passes regulatory hurdles, the company should further cement its leadership position in AI. In particular, the Arm deal would boost NVIDIA's presence in the fast-growing Internet of Things market with chips for mobile devices.</p>\n<p>Sure, an overall cryptocurrency crash could cause NVIDIA's shares to fall due to the popularity of the company's GPUs with crypto miners. It's happened before. However, the company has taken steps to segment its gaming business from crypto. I think that any pullback would only be temporary. NVIDIA has too many other strong growth drivers.</p>\n<h2>Moderna</h2>\n<p>Most companies can't honestly say that they've helped change the world.&nbsp;<b>Moderna</b> (NASDAQ:MRNA) can.</p>\n<p>The biotech's COVID-19 vaccine was second only to the vaccine developed by <b>Pfizer</b>&nbsp;and <b>BioNTech</b> to win U.S. Emergency Use Authorization (EUA). Moderna reported $1.9 billion in sales for the vaccine in Q1, but that's just the tip of the iceberg.</p>\n<p>Based on supply agreements in place as of early May, Moderna projected that its COVID-19 vaccine would rake in sales this year of $19.2 billion. However, the company has secured additional deals since then.</p>\n<p>In just the past two weeks, Moderna has landed two new huge supply agreements. The U.S. government is buying 200 million additional doses of Moderna's COVID19 vaccine. The European Commission agreed to purchase another 150 million doses.</p>\n<p>But does Moderna's market cap of close to $90 billion already price all of this growth in? To some extent, yes. However, shares still are trading at only around 10.5 times expected earnings. That's an attractive valuation, especially for a biotech stock.</p>\n<p>The big question for Moderna is how strong the recurring revenue from its COVID-19 vaccine will be. While the sales levels of 2021 and 2022 might not be sustainable over the long run, annual vaccinations could be likely (especially with emerging coronavirus variants). I expect Moderna will be able to count on significant COVID-19 vaccine sales for years to come.</p>\n<p>Then there's the pipeline. Moderna plans to advance its cytomegalovirus (CMV) vaccine into late-stage testing this year. It could easily be a megablockbuster if approved. The company has a dozen other programs in clinical testing.</p>\n<p>Moderna hopes to use its newfound riches to dramatically boost its pipeline in the near future. CEO Stephane Bancel has stated that he'd like to have up to 50 clinical programs.</p>\n<p>All of Moderna's current and planned pipeline programs are based on its messenger RNA (mRNA) technology. The company has maintained for a long time that if its mRNA approach worked for one disease, it would work for many diseases. If Moderna is right, the biotech stock should be a massive winner over the long run -- and could very well crush Dogecoin.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Robinhood Stocks That Could Crush Dogecoin</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Robinhood Stocks That Could Crush Dogecoin\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-29 17:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/28/2-robinhood-stocks-that-could-crush-dogecoin/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dogecoin (CRYPTO:DOGE) fans would be quick to point out that the cryptocurrency has skyrocketed more than 4,500% year to date. What started out as a joke has enabled some to laugh all the way to the ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/28/2-robinhood-stocks-that-could-crush-dogecoin/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/06/28/2-robinhood-stocks-that-could-crush-dogecoin/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2146388793","content_text":"Dogecoin (CRYPTO:DOGE) fans would be quick to point out that the cryptocurrency has skyrocketed more than 4,500% year to date. What started out as a joke has enabled some to laugh all the way to the bank.\nOn the other hand, skeptics about Dogecoin would be just as quick to note that it has given up more than 60% of its earlier gains. Anyone who jumped on the Dogecoin late is probably sitting on some hefty losses.\nRegardless of what your take is on Dogecoin, what really matters is where you should put your money now. One place to get some investment ideas is Robinhood's 100 most popular stocks list. Here are two popular Robinhood stocks that could crush Dogecoin going forward.\nImage source: Getty Images.\nNVIDIA\nWhile Dogecoin has nosedived in recent months, NVIDIA (NASDAQ:NVDA) stock has taken off. One reason why is NVIDIA's upcoming four-for-one stock split. While stock splits don't impact a company's valuation directly, they can attract greater numbers of small investors.\nHowever, there are plenty of even better reasons to like NVIDIA that have nothing to do with its stock split. The most obvious one is the company's gaming business.\nGaming remains NVIDIA's biggest moneymaker, generating $2.8 billion of the company's total revenue of nearly $5.7 billion in the first quarter of 2021. And business is booming. NVIDIA's gaming revenue more than doubled year over year.\nIt isn't just that gaming is increasing in popularity (although that is the case). NVIDIA benefits from regular hardware upgrade cycles. New games require even more processing power, which drives demand for the more powerful graphics processing units (GPUs).\nI especially like that NVIDIA is leveraging its gaming expertise to target new markets. For example, the company recently unveiled Omniverse Enterprise, a platform where design teams can build 3D virtual simulations and collaborate in real-time. In effect, NVIDIA is turning work into play (or vice versa, depending on how you look at it).\nNVIDIA CFO Colette Kress said in the company's Q1 conference call, \"As the world becomes more digital, virtual and collaborative, we see a significant revenue opportunity for Omniverse.\" I think that Kress's optimism is well-founded.\nDon't overlook NVIDIA's potential in the data center market, though. The company posted data center revenue of more than $2 billion in Q1, up 79% year over year. NVIDIA should enjoy sustained growth as more applications include artificial intelligence (AI).\nAssuming NVIDIA's pending acquisition of Arm passes regulatory hurdles, the company should further cement its leadership position in AI. In particular, the Arm deal would boost NVIDIA's presence in the fast-growing Internet of Things market with chips for mobile devices.\nSure, an overall cryptocurrency crash could cause NVIDIA's shares to fall due to the popularity of the company's GPUs with crypto miners. It's happened before. However, the company has taken steps to segment its gaming business from crypto. I think that any pullback would only be temporary. NVIDIA has too many other strong growth drivers.\nModerna\nMost companies can't honestly say that they've helped change the world. Moderna (NASDAQ:MRNA) can.\nThe biotech's COVID-19 vaccine was second only to the vaccine developed by Pfizer and BioNTech to win U.S. Emergency Use Authorization (EUA). Moderna reported $1.9 billion in sales for the vaccine in Q1, but that's just the tip of the iceberg.\nBased on supply agreements in place as of early May, Moderna projected that its COVID-19 vaccine would rake in sales this year of $19.2 billion. However, the company has secured additional deals since then.\nIn just the past two weeks, Moderna has landed two new huge supply agreements. The U.S. government is buying 200 million additional doses of Moderna's COVID19 vaccine. The European Commission agreed to purchase another 150 million doses.\nBut does Moderna's market cap of close to $90 billion already price all of this growth in? To some extent, yes. However, shares still are trading at only around 10.5 times expected earnings. That's an attractive valuation, especially for a biotech stock.\nThe big question for Moderna is how strong the recurring revenue from its COVID-19 vaccine will be. While the sales levels of 2021 and 2022 might not be sustainable over the long run, annual vaccinations could be likely (especially with emerging coronavirus variants). I expect Moderna will be able to count on significant COVID-19 vaccine sales for years to come.\nThen there's the pipeline. Moderna plans to advance its cytomegalovirus (CMV) vaccine into late-stage testing this year. It could easily be a megablockbuster if approved. The company has a dozen other programs in clinical testing.\nModerna hopes to use its newfound riches to dramatically boost its pipeline in the near future. CEO Stephane Bancel has stated that he'd like to have up to 50 clinical programs.\nAll of Moderna's current and planned pipeline programs are based on its messenger RNA (mRNA) technology. The company has maintained for a long time that if its mRNA approach worked for one disease, it would work for many diseases. If Moderna is right, the biotech stock should be a massive winner over the long run -- and could very well crush Dogecoin.","news_type":1,"symbols_score_info":{"MRNA":0.9,"NVDA":0.9}},"isVote":1,"tweetType":1,"viewCount":121,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":163195614,"gmtCreate":1623861630038,"gmtModify":1634026822728,"author":{"id":"3574486316260209","authorId":"3574486316260209","name":"MarcyMarc","avatar":"https://static.tigerbbs.com/676954ae064ead813cc75835e6ca0924","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574486316260209","idStr":"3574486316260209"},"themes":[],"htmlText":"O","listText":"O","text":"O","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/163195614","repostId":"2143497767","repostType":4,"isVote":1,"tweetType":1,"viewCount":116,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":119465655,"gmtCreate":1622559495677,"gmtModify":1634100460849,"author":{"id":"3574486316260209","authorId":"3574486316260209","name":"MarcyMarc","avatar":"https://static.tigerbbs.com/676954ae064ead813cc75835e6ca0924","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574486316260209","idStr":"3574486316260209"},"themes":[],"htmlText":"You’re a dreamer mate if you think apple is gonna drop below $90. What a joker&nbsp;","listText":"You’re a dreamer mate if you think apple is gonna drop below $90. What a joker&nbsp;","text":"You’re a dreamer mate if you think apple is gonna drop below $90. What a joker","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/119465655","repostId":"1107522849","repostType":4,"repost":{"id":"1107522849","kind":"news","pubTimestamp":1622546178,"share":"https://ttm.financial/m/news/1107522849?lang=&edition=full","pubTime":"2021-06-01 19:16","market":"us","language":"en","title":"Apple Stock To Sink 30%? Inside The Mind Of A Bear","url":"https://stock-news.laohu8.com/highlight/detail?id=1107522849","media":"TheStreet","summary":"There is a new bear roaming the Apple orchard. Could Apple stock dip about 30% from current levels, as one Wall Street analyst argues?Anew bear has emerged from its cave. New Street’s Pierre Ferragu believes that Apple stock is now a sell, downgraded from his previous neutral stance, and that shares could sink by nearly 30% from current levels to only $90.The Apple Maven gets inside the mind of this Wall Street skeptic to better understand the potential risks of investing in Apple stock today.Pi","content":"<p>There is a new bear roaming the Apple orchard. Could Apple stock dip about 30% from current levels, as one Wall Street analyst argues?</p>\n<p>Anew bear has&nbsp;emerged&nbsp;from its cave. New Street’s Pierre Ferragu believes that Apple stock is now a sell, downgraded from his previous neutral stance, and that shares could sink by nearly 30% from current levels to only $90.</p>\n<p>The Apple Maven gets inside the mind of this Wall Street skeptic to better understand the potential risks of investing in Apple stock today.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/bd3a0c90859283b1acacd5c5258f1e15\" tg-width=\"1240\" tg-height=\"827\"><span>Figure 1: Wall Street bear.</span></p>\n<p><b>“12S cycle” coming up?</b></p>\n<p>New Street is effectively the only true Apple bear on Wall Street today. Famed skeptic Rod Hall, at Goldman Sachs, finally&nbsp;threw in the towel&nbsp;after the Cupertino company delivered&nbsp;a record-breaking fiscal second quarter. Wolfe Research’s Jeff Kvaal&nbsp;maintains his sell rating, but at a high price target of $125 that suggests minimal downside risk.</p>\n<p>Pierre Ferragu goes deeper. In his view, the best of Apple’s iPhone upgrade wave, the&nbsp;so-called 5G super cycle, has been left in the rearview mirror. The point was reinforced by the analyst’s views that the Cupertino company’s upcoming smartphone will probably be a “12S model” with limited updates.</p>\n<p>In addition to an underwhelming 2021 iPhone model in the pipeline, Mr. Ferragu’s bearish thesis is further illustrated by his quote below:</p>\n<blockquote>\n “The key question is how things shape up for next year, as the current super cycle has brought forward demand […] and consumers spend less on consumer electronics as the economy re-opens.”\n</blockquote>\n<p><b>Plugging some numbers</b></p>\n<p>New Street offered some figures to back up the 30% downside risk. According to the analyst, 2022 iPhone shipments would land at 190 million units, at the mid-point of the guidance range.</p>\n<p>If ASPs (average selling prices) remain elevated, as they have been in the first two quarters of fiscal 2021, the bear case points at next-year iPhone revenues of around $150 billion. At these levels, iPhone sales would have increased by a modest 5% per year through the COVID-19 crisis and pandemic recovery, against what I estimate to be nearly 20% consensus growth.</p>\n<p>Considering how relevant the iPhone still is to Apple’s financial performance (50% of total company sales in fiscal 2020), low growth prospects would likely lead to valuation compression. The double whammy would come in the form of consensus-lagging EPS, a combination of which would be needed to support New Street’s $90 share price target.</p>\n<p><b>The Apple Maven’s opinion</b></p>\n<p>One thing is clear: stock prices can swing wildly and correct sharply. Apple stock is no stranger to painful pullbacks. Shares have dipped by 40% or more from the peak (12% currently, plus the nearly 30% decline expected by New Street) several times before, as the chart below suggests.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/065aa03f398ac3a8622598724e214a02\" tg-width=\"665\" tg-height=\"398\"><span>Figure 2: Maximum drawdown in AAPL since IPO.</span></p>\n<p>But quite a bit would have to go wrong, in my opinion, for AAPL to return to $90 – levels not seen since the thick of the pandemic. From higher ASPs in 2021 to increased sales well past the peak of the stay-at-home buying spree, the iPhone seems to be experiencing a secular, not temporary increase in demand.</p>\n<p>Weakness in iPhone would likely need to come along muted results in other segments as well. In other words, Apple’s troubles would have to be broader, rather than product specific. To me, this would only be possible under two key assumptions:</p>\n<ul>\n <li>The post-pandemic “return to normal” will, indeed, cause discretionary spending to shift meaningfully away from tech devices and services – which I am skeptical about;</li>\n <li>The economy will endure a double-dip recession that cannot be remedied as well by fiscal and monetary stimuli –something that I also believe to be of low probability.</li>\n</ul>\n<p>At the end of the day, AAPL $90 is possible – just not highly likely, in my view.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple Stock To Sink 30%? Inside The Mind Of A Bear</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple Stock To Sink 30%? Inside The Mind Of A Bear\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-01 19:16 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/apple/stock/apple-stock-to-sink-30-inside-the-mind-of-a-bear><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>There is a new bear roaming the Apple orchard. Could Apple stock dip about 30% from current levels, as one Wall Street analyst argues?\nAnew bear has emerged from its cave. New Street’s Pierre Ferragu ...</p>\n\n<a href=\"https://www.thestreet.com/apple/stock/apple-stock-to-sink-30-inside-the-mind-of-a-bear\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.thestreet.com/apple/stock/apple-stock-to-sink-30-inside-the-mind-of-a-bear","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1107522849","content_text":"There is a new bear roaming the Apple orchard. Could Apple stock dip about 30% from current levels, as one Wall Street analyst argues?\nAnew bear has emerged from its cave. New Street’s Pierre Ferragu believes that Apple stock is now a sell, downgraded from his previous neutral stance, and that shares could sink by nearly 30% from current levels to only $90.\nThe Apple Maven gets inside the mind of this Wall Street skeptic to better understand the potential risks of investing in Apple stock today.\nFigure 1: Wall Street bear.\n“12S cycle” coming up?\nNew Street is effectively the only true Apple bear on Wall Street today. Famed skeptic Rod Hall, at Goldman Sachs, finally threw in the towel after the Cupertino company delivered a record-breaking fiscal second quarter. Wolfe Research’s Jeff Kvaal maintains his sell rating, but at a high price target of $125 that suggests minimal downside risk.\nPierre Ferragu goes deeper. In his view, the best of Apple’s iPhone upgrade wave, the so-called 5G super cycle, has been left in the rearview mirror. The point was reinforced by the analyst’s views that the Cupertino company’s upcoming smartphone will probably be a “12S model” with limited updates.\nIn addition to an underwhelming 2021 iPhone model in the pipeline, Mr. Ferragu’s bearish thesis is further illustrated by his quote below:\n\n “The key question is how things shape up for next year, as the current super cycle has brought forward demand […] and consumers spend less on consumer electronics as the economy re-opens.”\n\nPlugging some numbers\nNew Street offered some figures to back up the 30% downside risk. According to the analyst, 2022 iPhone shipments would land at 190 million units, at the mid-point of the guidance range.\nIf ASPs (average selling prices) remain elevated, as they have been in the first two quarters of fiscal 2021, the bear case points at next-year iPhone revenues of around $150 billion. At these levels, iPhone sales would have increased by a modest 5% per year through the COVID-19 crisis and pandemic recovery, against what I estimate to be nearly 20% consensus growth.\nConsidering how relevant the iPhone still is to Apple’s financial performance (50% of total company sales in fiscal 2020), low growth prospects would likely lead to valuation compression. The double whammy would come in the form of consensus-lagging EPS, a combination of which would be needed to support New Street’s $90 share price target.\nThe Apple Maven’s opinion\nOne thing is clear: stock prices can swing wildly and correct sharply. Apple stock is no stranger to painful pullbacks. Shares have dipped by 40% or more from the peak (12% currently, plus the nearly 30% decline expected by New Street) several times before, as the chart below suggests.\nFigure 2: Maximum drawdown in AAPL since IPO.\nBut quite a bit would have to go wrong, in my opinion, for AAPL to return to $90 – levels not seen since the thick of the pandemic. From higher ASPs in 2021 to increased sales well past the peak of the stay-at-home buying spree, the iPhone seems to be experiencing a secular, not temporary increase in demand.\nWeakness in iPhone would likely need to come along muted results in other segments as well. In other words, Apple’s troubles would have to be broader, rather than product specific. To me, this would only be possible under two key assumptions:\n\nThe post-pandemic “return to normal” will, indeed, cause discretionary spending to shift meaningfully away from tech devices and services – which I am skeptical about;\nThe economy will endure a double-dip recession that cannot be remedied as well by fiscal and monetary stimuli –something that I also believe to be of low probability.\n\nAt the end of the day, AAPL $90 is possible – just not highly likely, in my view.","news_type":1,"symbols_score_info":{"AAPL":0.9}},"isVote":1,"tweetType":1,"viewCount":193,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":323569371,"gmtCreate":1615356513893,"gmtModify":1703487817368,"author":{"id":"3574486316260209","authorId":"3574486316260209","name":"MarcyMarc","avatar":"https://static.tigerbbs.com/676954ae064ead813cc75835e6ca0924","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574486316260209","idStr":"3574486316260209"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/XOM\">$Exxon Mobil(XOM)$</a>🚀","listText":"<a href=\"https://laohu8.com/S/XOM\">$Exxon Mobil(XOM)$</a>🚀","text":"$Exxon Mobil(XOM)$🚀","images":[{"img":"https://static.tigerbbs.com/0720ed1cbac417d00ef64d5433aa22aa","width":"1242","height":"2001"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/323569371","isVote":1,"tweetType":1,"viewCount":192,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"hots":[{"id":119465655,"gmtCreate":1622559495677,"gmtModify":1634100460849,"author":{"id":"3574486316260209","authorId":"3574486316260209","name":"MarcyMarc","avatar":"https://static.tigerbbs.com/676954ae064ead813cc75835e6ca0924","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574486316260209","idStr":"3574486316260209"},"themes":[],"htmlText":"You’re a dreamer mate if you think apple is gonna drop below $90. What a joker&nbsp;","listText":"You’re a dreamer mate if you think apple is gonna drop below $90. What a joker&nbsp;","text":"You’re a dreamer mate if you think apple is gonna drop below $90. What a joker","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/119465655","repostId":"1107522849","repostType":4,"repost":{"id":"1107522849","kind":"news","pubTimestamp":1622546178,"share":"https://ttm.financial/m/news/1107522849?lang=&edition=full","pubTime":"2021-06-01 19:16","market":"us","language":"en","title":"Apple Stock To Sink 30%? Inside The Mind Of A Bear","url":"https://stock-news.laohu8.com/highlight/detail?id=1107522849","media":"TheStreet","summary":"There is a new bear roaming the Apple orchard. Could Apple stock dip about 30% from current levels, as one Wall Street analyst argues?Anew bear has emerged from its cave. New Street’s Pierre Ferragu believes that Apple stock is now a sell, downgraded from his previous neutral stance, and that shares could sink by nearly 30% from current levels to only $90.The Apple Maven gets inside the mind of this Wall Street skeptic to better understand the potential risks of investing in Apple stock today.Pi","content":"<p>There is a new bear roaming the Apple orchard. Could Apple stock dip about 30% from current levels, as one Wall Street analyst argues?</p>\n<p>Anew bear has&nbsp;emerged&nbsp;from its cave. New Street’s Pierre Ferragu believes that Apple stock is now a sell, downgraded from his previous neutral stance, and that shares could sink by nearly 30% from current levels to only $90.</p>\n<p>The Apple Maven gets inside the mind of this Wall Street skeptic to better understand the potential risks of investing in Apple stock today.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/bd3a0c90859283b1acacd5c5258f1e15\" tg-width=\"1240\" tg-height=\"827\"><span>Figure 1: Wall Street bear.</span></p>\n<p><b>“12S cycle” coming up?</b></p>\n<p>New Street is effectively the only true Apple bear on Wall Street today. Famed skeptic Rod Hall, at Goldman Sachs, finally&nbsp;threw in the towel&nbsp;after the Cupertino company delivered&nbsp;a record-breaking fiscal second quarter. Wolfe Research’s Jeff Kvaal&nbsp;maintains his sell rating, but at a high price target of $125 that suggests minimal downside risk.</p>\n<p>Pierre Ferragu goes deeper. In his view, the best of Apple’s iPhone upgrade wave, the&nbsp;so-called 5G super cycle, has been left in the rearview mirror. The point was reinforced by the analyst’s views that the Cupertino company’s upcoming smartphone will probably be a “12S model” with limited updates.</p>\n<p>In addition to an underwhelming 2021 iPhone model in the pipeline, Mr. Ferragu’s bearish thesis is further illustrated by his quote below:</p>\n<blockquote>\n “The key question is how things shape up for next year, as the current super cycle has brought forward demand […] and consumers spend less on consumer electronics as the economy re-opens.”\n</blockquote>\n<p><b>Plugging some numbers</b></p>\n<p>New Street offered some figures to back up the 30% downside risk. According to the analyst, 2022 iPhone shipments would land at 190 million units, at the mid-point of the guidance range.</p>\n<p>If ASPs (average selling prices) remain elevated, as they have been in the first two quarters of fiscal 2021, the bear case points at next-year iPhone revenues of around $150 billion. At these levels, iPhone sales would have increased by a modest 5% per year through the COVID-19 crisis and pandemic recovery, against what I estimate to be nearly 20% consensus growth.</p>\n<p>Considering how relevant the iPhone still is to Apple’s financial performance (50% of total company sales in fiscal 2020), low growth prospects would likely lead to valuation compression. The double whammy would come in the form of consensus-lagging EPS, a combination of which would be needed to support New Street’s $90 share price target.</p>\n<p><b>The Apple Maven’s opinion</b></p>\n<p>One thing is clear: stock prices can swing wildly and correct sharply. Apple stock is no stranger to painful pullbacks. Shares have dipped by 40% or more from the peak (12% currently, plus the nearly 30% decline expected by New Street) several times before, as the chart below suggests.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/065aa03f398ac3a8622598724e214a02\" tg-width=\"665\" tg-height=\"398\"><span>Figure 2: Maximum drawdown in AAPL since IPO.</span></p>\n<p>But quite a bit would have to go wrong, in my opinion, for AAPL to return to $90 – levels not seen since the thick of the pandemic. From higher ASPs in 2021 to increased sales well past the peak of the stay-at-home buying spree, the iPhone seems to be experiencing a secular, not temporary increase in demand.</p>\n<p>Weakness in iPhone would likely need to come along muted results in other segments as well. In other words, Apple’s troubles would have to be broader, rather than product specific. To me, this would only be possible under two key assumptions:</p>\n<ul>\n <li>The post-pandemic “return to normal” will, indeed, cause discretionary spending to shift meaningfully away from tech devices and services – which I am skeptical about;</li>\n <li>The economy will endure a double-dip recession that cannot be remedied as well by fiscal and monetary stimuli –something that I also believe to be of low probability.</li>\n</ul>\n<p>At the end of the day, AAPL $90 is possible – just not highly likely, in my view.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple Stock To Sink 30%? Inside The Mind Of A Bear</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple Stock To Sink 30%? Inside The Mind Of A Bear\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-01 19:16 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/apple/stock/apple-stock-to-sink-30-inside-the-mind-of-a-bear><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>There is a new bear roaming the Apple orchard. Could Apple stock dip about 30% from current levels, as one Wall Street analyst argues?\nAnew bear has emerged from its cave. New Street’s Pierre Ferragu ...</p>\n\n<a href=\"https://www.thestreet.com/apple/stock/apple-stock-to-sink-30-inside-the-mind-of-a-bear\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.thestreet.com/apple/stock/apple-stock-to-sink-30-inside-the-mind-of-a-bear","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1107522849","content_text":"There is a new bear roaming the Apple orchard. Could Apple stock dip about 30% from current levels, as one Wall Street analyst argues?\nAnew bear has emerged from its cave. New Street’s Pierre Ferragu believes that Apple stock is now a sell, downgraded from his previous neutral stance, and that shares could sink by nearly 30% from current levels to only $90.\nThe Apple Maven gets inside the mind of this Wall Street skeptic to better understand the potential risks of investing in Apple stock today.\nFigure 1: Wall Street bear.\n“12S cycle” coming up?\nNew Street is effectively the only true Apple bear on Wall Street today. Famed skeptic Rod Hall, at Goldman Sachs, finally threw in the towel after the Cupertino company delivered a record-breaking fiscal second quarter. Wolfe Research’s Jeff Kvaal maintains his sell rating, but at a high price target of $125 that suggests minimal downside risk.\nPierre Ferragu goes deeper. In his view, the best of Apple’s iPhone upgrade wave, the so-called 5G super cycle, has been left in the rearview mirror. The point was reinforced by the analyst’s views that the Cupertino company’s upcoming smartphone will probably be a “12S model” with limited updates.\nIn addition to an underwhelming 2021 iPhone model in the pipeline, Mr. Ferragu’s bearish thesis is further illustrated by his quote below:\n\n “The key question is how things shape up for next year, as the current super cycle has brought forward demand […] and consumers spend less on consumer electronics as the economy re-opens.”\n\nPlugging some numbers\nNew Street offered some figures to back up the 30% downside risk. According to the analyst, 2022 iPhone shipments would land at 190 million units, at the mid-point of the guidance range.\nIf ASPs (average selling prices) remain elevated, as they have been in the first two quarters of fiscal 2021, the bear case points at next-year iPhone revenues of around $150 billion. At these levels, iPhone sales would have increased by a modest 5% per year through the COVID-19 crisis and pandemic recovery, against what I estimate to be nearly 20% consensus growth.\nConsidering how relevant the iPhone still is to Apple’s financial performance (50% of total company sales in fiscal 2020), low growth prospects would likely lead to valuation compression. The double whammy would come in the form of consensus-lagging EPS, a combination of which would be needed to support New Street’s $90 share price target.\nThe Apple Maven’s opinion\nOne thing is clear: stock prices can swing wildly and correct sharply. Apple stock is no stranger to painful pullbacks. Shares have dipped by 40% or more from the peak (12% currently, plus the nearly 30% decline expected by New Street) several times before, as the chart below suggests.\nFigure 2: Maximum drawdown in AAPL since IPO.\nBut quite a bit would have to go wrong, in my opinion, for AAPL to return to $90 – levels not seen since the thick of the pandemic. From higher ASPs in 2021 to increased sales well past the peak of the stay-at-home buying spree, the iPhone seems to be experiencing a secular, not temporary increase in demand.\nWeakness in iPhone would likely need to come along muted results in other segments as well. In other words, Apple’s troubles would have to be broader, rather than product specific. To me, this would only be possible under two key assumptions:\n\nThe post-pandemic “return to normal” will, indeed, cause discretionary spending to shift meaningfully away from tech devices and services – which I am skeptical about;\nThe economy will endure a double-dip recession that cannot be remedied as well by fiscal and monetary stimuli –something that I also believe to be of low probability.\n\nAt the end of the day, AAPL $90 is possible – just not highly likely, in my view.","news_type":1,"symbols_score_info":{"AAPL":0.9}},"isVote":1,"tweetType":1,"viewCount":193,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":810119322,"gmtCreate":1629951371266,"gmtModify":1633681217102,"author":{"id":"3574486316260209","authorId":"3574486316260209","name":"MarcyMarc","avatar":"https://static.tigerbbs.com/676954ae064ead813cc75835e6ca0924","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574486316260209","idStr":"3574486316260209"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/810119322","repostId":"2162525350","repostType":4,"isVote":1,"tweetType":1,"viewCount":129,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":323569371,"gmtCreate":1615356513893,"gmtModify":1703487817368,"author":{"id":"3574486316260209","authorId":"3574486316260209","name":"MarcyMarc","avatar":"https://static.tigerbbs.com/676954ae064ead813cc75835e6ca0924","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574486316260209","idStr":"3574486316260209"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/XOM\">$Exxon Mobil(XOM)$</a>🚀","listText":"<a href=\"https://laohu8.com/S/XOM\">$Exxon Mobil(XOM)$</a>🚀","text":"$Exxon Mobil(XOM)$🚀","images":[{"img":"https://static.tigerbbs.com/0720ed1cbac417d00ef64d5433aa22aa","width":"1242","height":"2001"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/323569371","isVote":1,"tweetType":1,"viewCount":192,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":159613338,"gmtCreate":1624961552524,"gmtModify":1633946498723,"author":{"id":"3574486316260209","authorId":"3574486316260209","name":"MarcyMarc","avatar":"https://static.tigerbbs.com/676954ae064ead813cc75835e6ca0924","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574486316260209","idStr":"3574486316260209"},"themes":[],"htmlText":"O","listText":"O","text":"O","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/159613338","repostId":"2146388793","repostType":4,"repost":{"id":"2146388793","kind":"highlight","pubTimestamp":1624959775,"share":"https://ttm.financial/m/news/2146388793?lang=&edition=full","pubTime":"2021-06-29 17:42","market":"us","language":"en","title":"2 Robinhood Stocks That Could Crush Dogecoin","url":"https://stock-news.laohu8.com/highlight/detail?id=2146388793","media":"Motley Fool","summary":"They're already big winners but could have much more room to run.","content":"<p><b>Dogecoin</b> (CRYPTO:DOGE) fans would be quick to point out that the cryptocurrency has skyrocketed more than 4,500% year to date. What started out as a joke has enabled some to laugh all the way to the bank.</p>\n<p>On the other hand, skeptics about Dogecoin would be just as quick to note that it has given up more than 60% of its earlier gains. Anyone who jumped on the Dogecoin late is probably sitting on some hefty losses.</p>\n<p>Regardless of what your take is on Dogecoin, what really matters is where you should put your money now. One place to get some investment ideas is Robinhood's 100 most popular stocks list. Here are two popular Robinhood stocks that could crush Dogecoin going forward.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/21859b0af15cb96a0c3a3aa3d6358251\" tg-width=\"700\" tg-height=\"420\" referrerpolicy=\"no-referrer\"><span>Image source: Getty Images.</span></p>\n<h2>NVIDIA</h2>\n<p>While Dogecoin has nosedived in recent months, <b>NVIDIA</b> (NASDAQ:NVDA) stock has taken off. One reason why is NVIDIA's upcoming four-for-<a href=\"https://laohu8.com/S/AONE\">one</a> stock split. While stock splits don't impact a company's valuation directly, they can attract greater numbers of small investors.</p>\n<p>However, there are plenty of even better reasons to like NVIDIA that have nothing to do with its stock split. The most obvious one is the company's gaming business.</p>\n<p>Gaming remains NVIDIA's biggest moneymaker, generating $2.8 billion of the company's total revenue of nearly $5.7 billion in the first quarter of 2021. And business is booming. NVIDIA's gaming revenue more than doubled year over year.</p>\n<p>It isn't just that gaming is increasing in popularity (although that is the case). NVIDIA benefits from regular hardware upgrade cycles. New games require even more processing power, which drives demand for the more powerful graphics processing units (GPUs).</p>\n<p>I especially like that NVIDIA is leveraging its gaming expertise to target new markets. For example, the company recently unveiled Omniverse Enterprise, a platform where design teams can build 3D virtual simulations and collaborate in real-time. In effect, NVIDIA is turning work into play (or vice versa, depending on how you look at it).</p>\n<p>NVIDIA CFO Colette Kress said in the company's Q1 conference call, \"As the world becomes more digital, virtual and collaborative, we see a significant revenue opportunity for Omniverse.\" I think that Kress's optimism is well-founded.</p>\n<p>Don't overlook NVIDIA's potential in the data center market, though. The company posted data center revenue of more than $2 billion in Q1, up 79% year over year. NVIDIA should enjoy sustained growth as more applications include artificial intelligence (AI).</p>\n<p>Assuming NVIDIA's pending acquisition of Arm passes regulatory hurdles, the company should further cement its leadership position in AI. In particular, the Arm deal would boost NVIDIA's presence in the fast-growing Internet of Things market with chips for mobile devices.</p>\n<p>Sure, an overall cryptocurrency crash could cause NVIDIA's shares to fall due to the popularity of the company's GPUs with crypto miners. It's happened before. However, the company has taken steps to segment its gaming business from crypto. I think that any pullback would only be temporary. NVIDIA has too many other strong growth drivers.</p>\n<h2>Moderna</h2>\n<p>Most companies can't honestly say that they've helped change the world.&nbsp;<b>Moderna</b> (NASDAQ:MRNA) can.</p>\n<p>The biotech's COVID-19 vaccine was second only to the vaccine developed by <b>Pfizer</b>&nbsp;and <b>BioNTech</b> to win U.S. Emergency Use Authorization (EUA). Moderna reported $1.9 billion in sales for the vaccine in Q1, but that's just the tip of the iceberg.</p>\n<p>Based on supply agreements in place as of early May, Moderna projected that its COVID-19 vaccine would rake in sales this year of $19.2 billion. However, the company has secured additional deals since then.</p>\n<p>In just the past two weeks, Moderna has landed two new huge supply agreements. The U.S. government is buying 200 million additional doses of Moderna's COVID19 vaccine. The European Commission agreed to purchase another 150 million doses.</p>\n<p>But does Moderna's market cap of close to $90 billion already price all of this growth in? To some extent, yes. However, shares still are trading at only around 10.5 times expected earnings. That's an attractive valuation, especially for a biotech stock.</p>\n<p>The big question for Moderna is how strong the recurring revenue from its COVID-19 vaccine will be. While the sales levels of 2021 and 2022 might not be sustainable over the long run, annual vaccinations could be likely (especially with emerging coronavirus variants). I expect Moderna will be able to count on significant COVID-19 vaccine sales for years to come.</p>\n<p>Then there's the pipeline. Moderna plans to advance its cytomegalovirus (CMV) vaccine into late-stage testing this year. It could easily be a megablockbuster if approved. The company has a dozen other programs in clinical testing.</p>\n<p>Moderna hopes to use its newfound riches to dramatically boost its pipeline in the near future. CEO Stephane Bancel has stated that he'd like to have up to 50 clinical programs.</p>\n<p>All of Moderna's current and planned pipeline programs are based on its messenger RNA (mRNA) technology. The company has maintained for a long time that if its mRNA approach worked for one disease, it would work for many diseases. If Moderna is right, the biotech stock should be a massive winner over the long run -- and could very well crush Dogecoin.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Robinhood Stocks That Could Crush Dogecoin</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Robinhood Stocks That Could Crush Dogecoin\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-29 17:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/28/2-robinhood-stocks-that-could-crush-dogecoin/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dogecoin (CRYPTO:DOGE) fans would be quick to point out that the cryptocurrency has skyrocketed more than 4,500% year to date. What started out as a joke has enabled some to laugh all the way to the ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/28/2-robinhood-stocks-that-could-crush-dogecoin/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/06/28/2-robinhood-stocks-that-could-crush-dogecoin/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2146388793","content_text":"Dogecoin (CRYPTO:DOGE) fans would be quick to point out that the cryptocurrency has skyrocketed more than 4,500% year to date. What started out as a joke has enabled some to laugh all the way to the bank.\nOn the other hand, skeptics about Dogecoin would be just as quick to note that it has given up more than 60% of its earlier gains. Anyone who jumped on the Dogecoin late is probably sitting on some hefty losses.\nRegardless of what your take is on Dogecoin, what really matters is where you should put your money now. One place to get some investment ideas is Robinhood's 100 most popular stocks list. Here are two popular Robinhood stocks that could crush Dogecoin going forward.\nImage source: Getty Images.\nNVIDIA\nWhile Dogecoin has nosedived in recent months, NVIDIA (NASDAQ:NVDA) stock has taken off. One reason why is NVIDIA's upcoming four-for-one stock split. While stock splits don't impact a company's valuation directly, they can attract greater numbers of small investors.\nHowever, there are plenty of even better reasons to like NVIDIA that have nothing to do with its stock split. The most obvious one is the company's gaming business.\nGaming remains NVIDIA's biggest moneymaker, generating $2.8 billion of the company's total revenue of nearly $5.7 billion in the first quarter of 2021. And business is booming. NVIDIA's gaming revenue more than doubled year over year.\nIt isn't just that gaming is increasing in popularity (although that is the case). NVIDIA benefits from regular hardware upgrade cycles. New games require even more processing power, which drives demand for the more powerful graphics processing units (GPUs).\nI especially like that NVIDIA is leveraging its gaming expertise to target new markets. For example, the company recently unveiled Omniverse Enterprise, a platform where design teams can build 3D virtual simulations and collaborate in real-time. In effect, NVIDIA is turning work into play (or vice versa, depending on how you look at it).\nNVIDIA CFO Colette Kress said in the company's Q1 conference call, \"As the world becomes more digital, virtual and collaborative, we see a significant revenue opportunity for Omniverse.\" I think that Kress's optimism is well-founded.\nDon't overlook NVIDIA's potential in the data center market, though. The company posted data center revenue of more than $2 billion in Q1, up 79% year over year. NVIDIA should enjoy sustained growth as more applications include artificial intelligence (AI).\nAssuming NVIDIA's pending acquisition of Arm passes regulatory hurdles, the company should further cement its leadership position in AI. In particular, the Arm deal would boost NVIDIA's presence in the fast-growing Internet of Things market with chips for mobile devices.\nSure, an overall cryptocurrency crash could cause NVIDIA's shares to fall due to the popularity of the company's GPUs with crypto miners. It's happened before. However, the company has taken steps to segment its gaming business from crypto. I think that any pullback would only be temporary. NVIDIA has too many other strong growth drivers.\nModerna\nMost companies can't honestly say that they've helped change the world. Moderna (NASDAQ:MRNA) can.\nThe biotech's COVID-19 vaccine was second only to the vaccine developed by Pfizer and BioNTech to win U.S. Emergency Use Authorization (EUA). Moderna reported $1.9 billion in sales for the vaccine in Q1, but that's just the tip of the iceberg.\nBased on supply agreements in place as of early May, Moderna projected that its COVID-19 vaccine would rake in sales this year of $19.2 billion. However, the company has secured additional deals since then.\nIn just the past two weeks, Moderna has landed two new huge supply agreements. The U.S. government is buying 200 million additional doses of Moderna's COVID19 vaccine. The European Commission agreed to purchase another 150 million doses.\nBut does Moderna's market cap of close to $90 billion already price all of this growth in? To some extent, yes. However, shares still are trading at only around 10.5 times expected earnings. That's an attractive valuation, especially for a biotech stock.\nThe big question for Moderna is how strong the recurring revenue from its COVID-19 vaccine will be. While the sales levels of 2021 and 2022 might not be sustainable over the long run, annual vaccinations could be likely (especially with emerging coronavirus variants). I expect Moderna will be able to count on significant COVID-19 vaccine sales for years to come.\nThen there's the pipeline. Moderna plans to advance its cytomegalovirus (CMV) vaccine into late-stage testing this year. It could easily be a megablockbuster if approved. The company has a dozen other programs in clinical testing.\nModerna hopes to use its newfound riches to dramatically boost its pipeline in the near future. CEO Stephane Bancel has stated that he'd like to have up to 50 clinical programs.\nAll of Moderna's current and planned pipeline programs are based on its messenger RNA (mRNA) technology. The company has maintained for a long time that if its mRNA approach worked for one disease, it would work for many diseases. If Moderna is right, the biotech stock should be a massive winner over the long run -- and could very well crush Dogecoin.","news_type":1,"symbols_score_info":{"MRNA":0.9,"NVDA":0.9}},"isVote":1,"tweetType":1,"viewCount":121,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":153236495,"gmtCreate":1625026535017,"gmtModify":1633945678020,"author":{"id":"3574486316260209","authorId":"3574486316260209","name":"MarcyMarc","avatar":"https://static.tigerbbs.com/676954ae064ead813cc75835e6ca0924","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574486316260209","idStr":"3574486316260209"},"themes":[],"htmlText":"Yep","listText":"Yep","text":"Yep","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/153236495","repostId":"2147585034","repostType":4,"repost":{"id":"2147585034","kind":"highlight","pubTimestamp":1625024760,"share":"https://ttm.financial/m/news/2147585034?lang=&edition=full","pubTime":"2021-06-30 11:46","market":"us","language":"en","title":"This Hot Reddit Stock Just Gave Investors an Ominous Warning","url":"https://stock-news.laohu8.com/highlight/detail?id=2147585034","media":"Motley Fool","summary":"It's a warning that investors should take seriously.","content":"<p>This year was shaping up to be a miserable <a href=\"https://laohu8.com/S/AONE\">one</a> for&nbsp;<b>Clover Health</b> (NASDAQ:CLOV). Note the use of the past tense in that statement, though. Thanks in large part to Reddit users piling on, Clover's shares have soared in recent weeks.</p>\n<p>Don't think that the waters are safe to jump aboard the bandwagon for Clover Health yet, however.&nbsp;Here's why this hot Reddit stock just gave investors an ominous warning.</p>\n<h2>Brutal honesty</h2>\n<p>All publicly traded companies want investors to buy their shares. Buying tends to beget more buying, which pushes the stock price up. It's rare that any company warns investors not to buy its stock. But that's exactly what Clover Health did recently.</p>\n<p>Companies that plan to issue additional shares file a prospectus with the U.S. Securities and Exchange Commission (SEC). This prospectus gives potential investors a lot of information about the business and lays out the key reasons why they might want to buy the new shares.</p>\n<p>Clover Health filed such a prospectus earlier this year, outlining its intent to issue additional Class B shares. These shares don't have the same level of voting rights as its Class A shares. Last week, the company submitted an amendment to the SEC for this prospectus. And that amendment contained a brutally honest message for potential investors.</p>\n<p>The company acknowledged that its recent gains could be due to a short squeeze. Because of the potential for an additional short squeeze and its aftermath, Clover Health gave an unusually stark warning to investors: \"Under the circumstances, we caution you against investing in our Class B common stock, unless you are prepared to incur the risk of losing all or a substantial portion of your investment.\" It also noted, \"Investors that purchase shares of our Class A common stock during a short squeeze may lose a significant portion of their investment.\"</p>\n<h2>No fear?</h2>\n<p>Clover Health explained clearly what could happen with both its Class A and Class B shares. The company stated that if another short squeeze happens, once short-sellers cover their positions or if investors otherwise think the short squeeze has run its course, its stock price could fall quickly.</p>\n<p>You might think that such an ominous warning would scare off many investors. Nope. Instead, it produced an opposite effect. Last week, shares of Clover Health soared by a double-digit percentage immediately after the company's amended prospectus with the serious warning was submitted to the SEC.</p>\n<p>This reaction might seem counterintuitive. After all, Clover Health informed investors in no uncertain terms about the risks they face with buying the stock. So why did the shares of the company surge instead of sink? I think there are different reasons for different investors.</p>\n<p>Some truly believe in Clover Health and are willing to hold onto the stock regardless of what happens over the short term. Others are fully aware that the gains generated by a short squeeze could evaporate quickly but think they'll be able to sell in time to still make a big profit. Unfortunately, there could also be some who are new to investing and didn't pay attention to or didn't understand Clover Health's cautionary message.</p>\n<h2>Business vs. stock</h2>\n<p>It's always wise to think of buying a stock as buying a part of a business. That's exactly what you're doing when you buy shares of Clover Health or any other company. When the underlying business is strong and has great prospects, you don't have to be concerned about short-term volatility with the share price.</p>\n<p>However, there are times when share prices get way out of alignment with the prospects of the underlying business. Short squeezes can often make this happen. In these cases, it's especially important to be careful in buying a stock. Sure, you're still buying a part of a business -- but you can pay a lot more than the business is actually worth.</p>\n<p>In my view, there are several reasons to like Clover Health's underlying business. The company has an intriguing technology that physicians use. It's expanding into the original Medicare market, a move that could boost sales tremendously. Clover Health has a visionary management team.</p>\n<p>But buying a stock that's a short squeeze candidate is risky if you aren't ready, willing, and able to sell shares immediately once the short squeeze ends. When a company issues a warning like Clover Health just did, the smart thing to do is to listen and take that warning seriously.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This Hot Reddit Stock Just Gave Investors an Ominous Warning</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Hot Reddit Stock Just Gave Investors an Ominous Warning\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-30 11:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/29/this-hot-reddit-stock-just-gave-investors-an-omino/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>This year was shaping up to be a miserable one for Clover Health (NASDAQ:CLOV). Note the use of the past tense in that statement, though. Thanks in large part to Reddit users piling on, Clover's ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/29/this-hot-reddit-stock-just-gave-investors-an-omino/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CLOV":"Clover Health Corp"},"source_url":"https://www.fool.com/investing/2021/06/29/this-hot-reddit-stock-just-gave-investors-an-omino/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2147585034","content_text":"This year was shaping up to be a miserable one for Clover Health (NASDAQ:CLOV). Note the use of the past tense in that statement, though. Thanks in large part to Reddit users piling on, Clover's shares have soared in recent weeks.\nDon't think that the waters are safe to jump aboard the bandwagon for Clover Health yet, however. Here's why this hot Reddit stock just gave investors an ominous warning.\nBrutal honesty\nAll publicly traded companies want investors to buy their shares. Buying tends to beget more buying, which pushes the stock price up. It's rare that any company warns investors not to buy its stock. But that's exactly what Clover Health did recently.\nCompanies that plan to issue additional shares file a prospectus with the U.S. Securities and Exchange Commission (SEC). This prospectus gives potential investors a lot of information about the business and lays out the key reasons why they might want to buy the new shares.\nClover Health filed such a prospectus earlier this year, outlining its intent to issue additional Class B shares. These shares don't have the same level of voting rights as its Class A shares. Last week, the company submitted an amendment to the SEC for this prospectus. And that amendment contained a brutally honest message for potential investors.\nThe company acknowledged that its recent gains could be due to a short squeeze. Because of the potential for an additional short squeeze and its aftermath, Clover Health gave an unusually stark warning to investors: \"Under the circumstances, we caution you against investing in our Class B common stock, unless you are prepared to incur the risk of losing all or a substantial portion of your investment.\" It also noted, \"Investors that purchase shares of our Class A common stock during a short squeeze may lose a significant portion of their investment.\"\nNo fear?\nClover Health explained clearly what could happen with both its Class A and Class B shares. The company stated that if another short squeeze happens, once short-sellers cover their positions or if investors otherwise think the short squeeze has run its course, its stock price could fall quickly.\nYou might think that such an ominous warning would scare off many investors. Nope. Instead, it produced an opposite effect. Last week, shares of Clover Health soared by a double-digit percentage immediately after the company's amended prospectus with the serious warning was submitted to the SEC.\nThis reaction might seem counterintuitive. After all, Clover Health informed investors in no uncertain terms about the risks they face with buying the stock. So why did the shares of the company surge instead of sink? I think there are different reasons for different investors.\nSome truly believe in Clover Health and are willing to hold onto the stock regardless of what happens over the short term. Others are fully aware that the gains generated by a short squeeze could evaporate quickly but think they'll be able to sell in time to still make a big profit. Unfortunately, there could also be some who are new to investing and didn't pay attention to or didn't understand Clover Health's cautionary message.\nBusiness vs. stock\nIt's always wise to think of buying a stock as buying a part of a business. That's exactly what you're doing when you buy shares of Clover Health or any other company. When the underlying business is strong and has great prospects, you don't have to be concerned about short-term volatility with the share price.\nHowever, there are times when share prices get way out of alignment with the prospects of the underlying business. Short squeezes can often make this happen. In these cases, it's especially important to be careful in buying a stock. Sure, you're still buying a part of a business -- but you can pay a lot more than the business is actually worth.\nIn my view, there are several reasons to like Clover Health's underlying business. The company has an intriguing technology that physicians use. It's expanding into the original Medicare market, a move that could boost sales tremendously. Clover Health has a visionary management team.\nBut buying a stock that's a short squeeze candidate is risky if you aren't ready, willing, and able to sell shares immediately once the short squeeze ends. When a company issues a warning like Clover Health just did, the smart thing to do is to listen and take that warning seriously.","news_type":1,"symbols_score_info":{"CLOV":0.9,"JE":0.9}},"isVote":1,"tweetType":1,"viewCount":97,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159614987,"gmtCreate":1624962079249,"gmtModify":1633946494973,"author":{"id":"3574486316260209","authorId":"3574486316260209","name":"MarcyMarc","avatar":"https://static.tigerbbs.com/676954ae064ead813cc75835e6ca0924","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574486316260209","idStr":"3574486316260209"},"themes":[],"htmlText":"Buy $$","listText":"Buy $$","text":"Buy $$","images":[{"img":"https://static.tigerbbs.com/23fe58a34f77ede65dad592912c6be86","width":"1125","height":"3005"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/159614987","isVote":1,"tweetType":1,"viewCount":86,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":159611198,"gmtCreate":1624961624914,"gmtModify":1633946497783,"author":{"id":"3574486316260209","authorId":"3574486316260209","name":"MarcyMarc","avatar":"https://static.tigerbbs.com/676954ae064ead813cc75835e6ca0924","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574486316260209","idStr":"3574486316260209"},"themes":[],"htmlText":"Haha&nbsp;","listText":"Haha&nbsp;","text":"Haha","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/159611198","repostId":"1176831724","repostType":4,"repost":{"id":"1176831724","kind":"news","pubTimestamp":1624954612,"share":"https://ttm.financial/m/news/1176831724?lang=&edition=full","pubTime":"2021-06-29 16:16","market":"us","language":"en","title":"Paysafe: One Payments Firm To Pass On For Now","url":"https://stock-news.laohu8.com/highlight/detail?id=1176831724","media":"seekingalpha","summary":"Summary\n\nPaysafe rallied to $12 based on inclusion in the Russell 3000 and Reddit mentions.\nThe paym","content":"<p><b>Summary</b></p>\n<ul>\n <li>Paysafe rallied to $12 based on inclusion in the Russell 3000 and Reddit mentions.</li>\n <li>The payments company is stuck with 10% growth despite the growth in the U.S. iGaming market.</li>\n <li>The stock trades at 23x '21 EV/EBITDA targets due to a $2 billion debt load.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/81a2561d10af7378c66d977c2bf5862d\" tg-width=\"1536\" tg-height=\"864\" referrerpolicy=\"no-referrer\"><span>shulz/E+ via Getty Images</span></p>\n<p>The fintech space remains red hot, but&nbsp;<b>Paysafe Limited</b>&nbsp;(PSFE) is one such company lacking the growth typical of the sector. The company is focused on payments in the iGaming space, but Paysafe just reported underwhelming&nbsp;Q1 results. My investment thesis is Neutral on the stock, but the iGaming sector keeps us interested in watching the story here for the long term.</p>\n<p><b>Underwhelming Q1</b></p>\n<p>Paysafe completed the&nbsp;business combination&nbsp;with the Foley Trasimene Acquisition Corp. II SPAC back on March 30. The stock originally traded as high as $19 on excitement over the growth potential of payments in the iGaming sector, but the company had meager guidance. Recently, Paysafe fell as low as $10 following weak numbers with the Q1 report.</p>\n<p>For Q1, the fintech reported revenues beat estimates by $11 million, but Paysafe only reported 4.9% revenue growth. The adjusted EBITDA number was flat at $113 million while payments volume did grow by 8% to $28 billion.</p>\n<p>The company reaffirmed guidance for 2021, but the market likely expected a number hike. Paysafe forecasts revenue of $1,540 million for only 10% growth over last year.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/fe39c5190f168da3f52950256c0df60c\" tg-width=\"640\" tg-height=\"176\"><span>Source: PaysafeQ1'21 earnings release</span></p>\n<p>The company has set a goal for 10%+ annualized organic revenue growth, but the market likely hoped this number was very conservative rather than actual results confirming this reality. The stock already has a market cap of ~$9 billion and an enterprise value of nearly $11 billion based on $2 billion in debt with Paysafe trading up at $12. The stock trades at an EV of nearly 23x the adjusted EBITDA target for 2021.</p>\n<p>Considering Paysafe already has 32% EBITDA margins, the story is far more mature than most SPAC stocks and maybe not what one expected of a payments company targeting the hot iGaming space with a digital wallet involved in the crypto space. The stock got a nice rally over the last few weeks due to the&nbsp;inclusion in the Russell 3000&nbsp;and some mentions from the Reddit crowd, so investors should steer clear here above $12 outside of short-term trade reasons.</p>\n<p><b>iGaming Payments Growth</b></p>\n<p>The company plays in all of the hot sectors with a payments platform focused on sports betting, online casinos, eSports and fantasy sports. Paysafe has a digital wallet that works withDraftKings(NASDAQ:DKNG)and bet365 while the eCash network works with Fortnite and Twitch, but most of the business is in the Integrated Processing payments segment where the take rate was only 1.1% last year.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/010ad43a352ec4ef93ded009a701449a\" tg-width=\"640\" tg-height=\"315\"><span>Source: Paysafe2021 investor day</span></p>\n<p>The U.S. iGaming market is growing at a 55% clip, but Paysafe is involved more in the online commerce market with growth closer to a 10% rate. Right now, the Europe and ROW segments have payments volumes up to 10x the U.S. market, but this segment is far more mature having launched all the way back in 1999.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/fcdc7bfb1551ec838f1edecc36980c0e\" tg-width=\"640\" tg-height=\"319\"><span>Source: Paysafe 2021 investor day</span></p>\n<p>The iGaming payment network is already live in 14 states in the U.S. with ~75% of the operators in those states, but the size of the market is swamped by Europe and such. Even if the U.S. iGaming payments market reaches 2025 targets of $24 billion in payment volumes, Europe and ROW is already a $78 billion payments market and will still reach nearly 3x the U.S. levels in 2025.</p>\n<p>Ultimately, the story just doesn't have the sizzle as some of the other payments stocks recently going public. Paysafe has solid 10% revenue growth ahead, but the company will have to find another catalyst to move the needle for investors in the payments space to really get excited by the story.</p>\n<p>Otherwise, Paysafe is a solid buy once the stock dips back to $10 following the recent Reddit and index inclusion rally. As the market better understands the $2 billion load, a lot of the upside could be limited.</p>\n<p><b>Takeaway</b></p>\n<p>The key investor takeaway is that Paysafe is a solid company in a growing market. Investors have to recognize the company is a 10% grower, not the 50% grower of the U.S. iGaming market due to other business operations outside of the U.S.</p>\n<p>Any more involvement in the crypto space could boost the growth story and make the stock more appealing. Investors interested in the fintech and payments space should keep Paysafe on a watch list to see how the story develops over time and possibly buy the stock on dips.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Paysafe: One Payments Firm To Pass On For Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPaysafe: One Payments Firm To Pass On For Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-29 16:16 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4436891-paysafe-one-payments-firm-to-pass-on-for-now><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nPaysafe rallied to $12 based on inclusion in the Russell 3000 and Reddit mentions.\nThe payments company is stuck with 10% growth despite the growth in the U.S. iGaming market.\nThe stock ...</p>\n\n<a href=\"https://seekingalpha.com/article/4436891-paysafe-one-payments-firm-to-pass-on-for-now\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://seekingalpha.com/article/4436891-paysafe-one-payments-firm-to-pass-on-for-now","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176831724","content_text":"Summary\n\nPaysafe rallied to $12 based on inclusion in the Russell 3000 and Reddit mentions.\nThe payments company is stuck with 10% growth despite the growth in the U.S. iGaming market.\nThe stock trades at 23x '21 EV/EBITDA targets due to a $2 billion debt load.\n\nshulz/E+ via Getty Images\nThe fintech space remains red hot, but Paysafe Limited (PSFE) is one such company lacking the growth typical of the sector. The company is focused on payments in the iGaming space, but Paysafe just reported underwhelming Q1 results. My investment thesis is Neutral on the stock, but the iGaming sector keeps us interested in watching the story here for the long term.\nUnderwhelming Q1\nPaysafe completed the business combination with the Foley Trasimene Acquisition Corp. II SPAC back on March 30. The stock originally traded as high as $19 on excitement over the growth potential of payments in the iGaming sector, but the company had meager guidance. Recently, Paysafe fell as low as $10 following weak numbers with the Q1 report.\nFor Q1, the fintech reported revenues beat estimates by $11 million, but Paysafe only reported 4.9% revenue growth. The adjusted EBITDA number was flat at $113 million while payments volume did grow by 8% to $28 billion.\nThe company reaffirmed guidance for 2021, but the market likely expected a number hike. Paysafe forecasts revenue of $1,540 million for only 10% growth over last year.\nSource: PaysafeQ1'21 earnings release\nThe company has set a goal for 10%+ annualized organic revenue growth, but the market likely hoped this number was very conservative rather than actual results confirming this reality. The stock already has a market cap of ~$9 billion and an enterprise value of nearly $11 billion based on $2 billion in debt with Paysafe trading up at $12. The stock trades at an EV of nearly 23x the adjusted EBITDA target for 2021.\nConsidering Paysafe already has 32% EBITDA margins, the story is far more mature than most SPAC stocks and maybe not what one expected of a payments company targeting the hot iGaming space with a digital wallet involved in the crypto space. The stock got a nice rally over the last few weeks due to the inclusion in the Russell 3000 and some mentions from the Reddit crowd, so investors should steer clear here above $12 outside of short-term trade reasons.\niGaming Payments Growth\nThe company plays in all of the hot sectors with a payments platform focused on sports betting, online casinos, eSports and fantasy sports. Paysafe has a digital wallet that works withDraftKings(NASDAQ:DKNG)and bet365 while the eCash network works with Fortnite and Twitch, but most of the business is in the Integrated Processing payments segment where the take rate was only 1.1% last year.\nSource: Paysafe2021 investor day\nThe U.S. iGaming market is growing at a 55% clip, but Paysafe is involved more in the online commerce market with growth closer to a 10% rate. Right now, the Europe and ROW segments have payments volumes up to 10x the U.S. market, but this segment is far more mature having launched all the way back in 1999.\nSource: Paysafe 2021 investor day\nThe iGaming payment network is already live in 14 states in the U.S. with ~75% of the operators in those states, but the size of the market is swamped by Europe and such. Even if the U.S. iGaming payments market reaches 2025 targets of $24 billion in payment volumes, Europe and ROW is already a $78 billion payments market and will still reach nearly 3x the U.S. levels in 2025.\nUltimately, the story just doesn't have the sizzle as some of the other payments stocks recently going public. Paysafe has solid 10% revenue growth ahead, but the company will have to find another catalyst to move the needle for investors in the payments space to really get excited by the story.\nOtherwise, Paysafe is a solid buy once the stock dips back to $10 following the recent Reddit and index inclusion rally. As the market better understands the $2 billion load, a lot of the upside could be limited.\nTakeaway\nThe key investor takeaway is that Paysafe is a solid company in a growing market. Investors have to recognize the company is a 10% grower, not the 50% grower of the U.S. iGaming market due to other business operations outside of the U.S.\nAny more involvement in the crypto space could boost the growth story and make the stock more appealing. Investors interested in the fintech and payments space should keep Paysafe on a watch list to see how the story develops over time and possibly buy the stock on dips.","news_type":1,"symbols_score_info":{"PSFE":0.9}},"isVote":1,"tweetType":1,"viewCount":86,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":163195614,"gmtCreate":1623861630038,"gmtModify":1634026822728,"author":{"id":"3574486316260209","authorId":"3574486316260209","name":"MarcyMarc","avatar":"https://static.tigerbbs.com/676954ae064ead813cc75835e6ca0924","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574486316260209","idStr":"3574486316260209"},"themes":[],"htmlText":"O","listText":"O","text":"O","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/163195614","repostId":"2143497767","repostType":4,"isVote":1,"tweetType":1,"viewCount":116,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}